findmyKOL
Clinical trialNCT04912323RecruitingInterventional

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

SponsorR3 Vascular Inc.Enrollment30Atherosclerotic LesionLower Extremity ClaudicationLower Extremity IschemiaPeripheral Arterial Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medical University Graz

    Graz, Austria

    Marianne Brodmann, MD
    Recruiting
Canada
  • Crchum Université Montreal

    Montreal, Canada

    Gilles Soulez, MD
    Recruiting
  • Hopital Saint-Francois D'Assise

    Québec, Canada

    Active, not recruiting
  • Toronto General Hospital

    Toronto, Canada

    Kong Teng Tan, MD
    Recruiting
Italy
  • San Donato Hospital

    Arezzo, Italy

    Francesco Liistro, MD
    Recruiting
  • Maria Cecilia Hospital

    Cotignola, Italy

    Luis M Palena, MD
    Recruiting
  • Irccs Multimedica

    Milan, Italy

    Flavio Airoldi, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Aug 2021
Primary completion
31 Dec 2026
Completion
31 Dec 2031
Last update posted
9 Apr 2024
Registered enrollment
30
Registry id
NCT04912323

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.